DE2831419C2 - - Google Patents
Info
- Publication number
- DE2831419C2 DE2831419C2 DE2831419A DE2831419A DE2831419C2 DE 2831419 C2 DE2831419 C2 DE 2831419C2 DE 2831419 A DE2831419 A DE 2831419A DE 2831419 A DE2831419 A DE 2831419A DE 2831419 C2 DE2831419 C2 DE 2831419C2
- Authority
- DE
- Germany
- Prior art keywords
- dispersion
- tetrafluoroethane
- dichlorodifluoromethane
- dichloro
- sorbitan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000006185 dispersion Substances 0.000 claims description 20
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 claims description 13
- 239000004338 Dichlorodifluoromethane Substances 0.000 claims description 13
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 13
- 235000019404 dichlorodifluoromethane Nutrition 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- -1 sorbitol ester Chemical class 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 9
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 8
- 229960000265 cromoglicic acid Drugs 0.000 claims description 8
- 235000010445 lecithin Nutrition 0.000 claims description 8
- 239000000787 lecithin Substances 0.000 claims description 8
- 229940067606 lecithin Drugs 0.000 claims description 8
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 7
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims description 7
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims description 7
- 229940029284 trichlorofluoromethane Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 description 15
- 239000004604 Blowing Agent Substances 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- WXGNWUVNYMJENI-UHFFFAOYSA-N 1,1,2,2-tetrafluoroethane Chemical compound FC(F)C(F)F WXGNWUVNYMJENI-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- QCGGXGCODUUTLZ-UHFFFAOYSA-N [Na].[Na].[Na].[Na] Chemical compound [Na].[Na].[Na].[Na] QCGGXGCODUUTLZ-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3016977 | 1977-07-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2831419A1 DE2831419A1 (de) | 1979-02-01 |
| DE2831419C2 true DE2831419C2 (enrdf_load_stackoverflow) | 1989-01-05 |
Family
ID=10303374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782831419 Granted DE2831419A1 (de) | 1977-07-19 | 1978-07-18 | Dispersion oder suspension aus lecithin oder einem sorbitan- oder sorbit-ester in treibmittel 12 |
Country Status (15)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| HU205249B (en) * | 1990-11-09 | 1992-04-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing suspensive aerosole composition |
| DE4425255A1 (de) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB367276A (en) * | 1931-06-20 | 1932-02-18 | Schmidt Sche Heissdampf | Improvements in or relating to independently fired steam superheaters |
| BE555319A (enrdf_load_stackoverflow) * | 1956-03-21 | 1900-01-01 | ||
| BE556587A (enrdf_load_stackoverflow) * | 1957-01-31 | 1957-04-11 | ||
| GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
| US3513104A (en) * | 1965-03-26 | 1970-05-19 | Colgate Palmolive Co | Self-propelling powder compositions |
| US3560507A (en) * | 1968-02-27 | 1971-02-02 | Millmaster Onyx Corp | Quaternary ammonium alkenyl succinates |
| ZA72434B (en) * | 1971-01-25 | 1973-09-26 | Colgate Palmolive Co | Fabric conditioning |
| DE2151706B1 (en) * | 1971-10-18 | 1973-05-03 | Cegla, Ulrich, Dr med , 600 0 Frank fürt Niederrad | Tantalum-contg x-ray contrast agents - in aerosol form for bronchography |
| IL44022A0 (en) * | 1973-01-23 | 1974-05-16 | Fisons Ltd | Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them |
| IT1039699B (it) * | 1975-07-03 | 1979-12-10 | Prephar | Composizione spermicida a base di derivati benzisotiazolici |
| GB1562901A (en) * | 1976-01-30 | 1980-03-19 | Fisons Ltd | Disodium cromoglycate |
| FI770215A7 (enrdf_load_stackoverflow) * | 1976-01-30 | 1977-07-31 | Fisons Ltd | |
| GB2001334B (en) | 1977-07-19 | 1982-03-03 | Fisons Ltd | Pressurised aerosol formulation |
| GB1590126A (en) | 1977-11-23 | 1981-05-28 | Booth B H | Method of bulking yarns |
-
1978
- 1978-07-14 AU AU38057/78A patent/AU522792B2/en not_active Expired
- 1978-07-17 IE IE1432/78A patent/IE47128B1/en not_active IP Right Cessation
- 1978-07-17 BE BE189326A patent/BE869055A/xx not_active IP Right Cessation
- 1978-07-17 CA CA307,480A patent/CA1112567A/en not_active Expired
- 1978-07-17 NL NL7807625A patent/NL7807625A/xx active Search and Examination
- 1978-07-17 FR FR7821172A patent/FR2397833A1/fr active Granted
- 1978-07-18 SE SE7807934A patent/SE443087B/sv not_active IP Right Cessation
- 1978-07-18 IL IL55161A patent/IL55161A/xx unknown
- 1978-07-18 DE DE19782831419 patent/DE2831419A1/de active Granted
- 1978-07-18 CH CH774178A patent/CH627075A5/fr not_active IP Right Cessation
- 1978-07-18 JP JP8682578A patent/JPS5435209A/ja active Granted
- 1978-07-18 IT IT25845/78A patent/IT1158890B/it active Protection Beyond IP Right Term
- 1978-07-18 NZ NZ187894A patent/NZ187894A/en unknown
-
1984
- 1984-12-30 MY MY252/84A patent/MY8400252A/xx unknown
-
1985
- 1985-07-04 HK HK515/85A patent/HK51585A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL55161A0 (en) | 1978-09-29 |
| SE7807934L (sv) | 1979-01-20 |
| IL55161A (en) | 1981-12-31 |
| IE47128B1 (en) | 1983-12-28 |
| BE869055A (fr) | 1979-01-17 |
| IE781432L (en) | 1979-01-19 |
| JPS6411615B2 (enrdf_load_stackoverflow) | 1989-02-27 |
| IT7825845A0 (it) | 1978-07-18 |
| FR2397833A1 (fr) | 1979-02-16 |
| NZ187894A (en) | 1984-05-31 |
| AU3805778A (en) | 1980-01-17 |
| FR2397833B1 (enrdf_load_stackoverflow) | 1982-06-25 |
| JPS5435209A (en) | 1979-03-15 |
| SE443087B (sv) | 1986-02-17 |
| NL7807625A (nl) | 1979-01-23 |
| IT1158890B (it) | 1987-02-25 |
| HK51585A (en) | 1985-07-12 |
| CH627075A5 (en) | 1981-12-31 |
| MY8400252A (en) | 1984-12-31 |
| DE2831419A1 (de) | 1979-02-01 |
| AU522792B2 (en) | 1982-06-24 |
| CA1112567A (en) | 1981-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69105212T2 (de) | Aerosolzubereitung, die beclometason 17,21-dipropionat enthält. | |
| DE69112635T2 (de) | Aerosole die arzneimittel enthalten. | |
| DE69131867T2 (de) | Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe | |
| DE69915144T2 (de) | Aerosoldruckdosiergeräte und Aerosolarzneizusammensetzungen | |
| DE69735497T2 (de) | Medizinische aerosolformulierungen enthaltend budesonid | |
| DE69101639T2 (de) | Anwendung von löslichen fluorhaltigen tensiden zur herstellung von aerosol-präparaten mit dosierter abgabe. | |
| DE3230743C2 (de) | Als Aerosol versprühbare Masse und Verfahren zu deren Herstellung | |
| DE69233076T3 (de) | Aerosolpräparate | |
| DE60003162T2 (de) | Modifizierte trägerpartikel zur verwendung in trockenpulverinhalatoren | |
| DE69730723T2 (de) | Medizinische aerosolformulierungen von formoterol | |
| DE2703119C2 (enrdf_load_stackoverflow) | ||
| EP1372608B1 (de) | Medizinische aerosolformulierungen | |
| DE1178975B (de) | Verfahren zum Herstellen eines Inhalationsmittels | |
| EP1809243B2 (de) | Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel | |
| DE69705628T2 (de) | Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat | |
| DE1492015A1 (de) | Verbesserte Verabreichungsform pharmazeutischer Praeparate | |
| DE69004066T2 (de) | Verfahren zur photostabilisierung von augenspüllösungen. | |
| DE60109202T2 (de) | Pharmazeutische aerosolformulierung | |
| DE68919642T2 (de) | Arzneimittel. | |
| DE102012102218A1 (de) | Ozon nicht abbauende medizinische Aerosolformulierungen | |
| DE69804998T2 (de) | Mometasonfuroat-suspensionen zum zerstäuben | |
| DE2831419C2 (enrdf_load_stackoverflow) | ||
| DE2639505B2 (enrdf_load_stackoverflow) | ||
| DE4203306A1 (de) | Asthma oder pulmonal-aerosolzubereitungen mit lecithin | |
| DE69015890T2 (de) | Aerosole von Pyrido(1,2-a)pyrimidinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8127 | New person/name/address of the applicant |
Owner name: FISONS PLC, IPSWICH, SUFFOLK, GB |
|
| 8128 | New person/name/address of the agent |
Representative=s name: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DI |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent | ||
| 8331 | Complete revocation |